Antibody Fc engineering improves frequency and promotes kinetic boosting of serial killing mediated by NK cells. - Test2 - elhamkhani - TriplyDB

Antibody Fc engineering improves frequency and promotes kinetic boosting of serial killing mediated by NK cells.

Antibody Fc engineering improves frequency and promotes kinetic boosting of serial killing mediated by NK cells.

http://www.wikidata.org/entity/Q34551199

about

The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer Single-cell analysis tools for drug discovery and development Automated profiling of individual cell-cell interactions from high-throughput time-lapse imaging microscopy in nanowell grids (TIMING)Microchip Screening Platform for Single Cell Assessment of NK Cell Cytotoxicity.Individual Motile CD4(+) T Cells Can Participate in Efficient Multikilling through Conjugation to Multiple Tumor Cells.Antibodies That Efficiently Form Hexamers upon Antigen Binding Can Induce Complement-Dependent Cytotoxicity under Complement-Limiting Conditions.Combinatorial antibody libraries: new advances, new immunological insights.Effect of CD16a, the surface receptor of Kupffer cells, on the growth of hepatocellular carcinoma cells.Decitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blasts Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets.Promise and problems associated with the use of recombinant AAV for the delivery of anti-HIV antibodies Multifaceted role of BTLA in the control of CD8+ T cell fate after antigen encounter.Antigen-specific immunotherapy for acute myeloid leukemia: where are we now, and where do we go from here?IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions.Antibody Engineering for Pursuing a Healthier Future Bridging the gap: microfluidic devices for short and long distance cell-cell communication.Chip-based platform for dynamic analysis of NK cell cytolysis mediated by a triplebody.Engineering Natural Killer Cells for Cancer Immunotherapy.Microwell-Based Live Cell Imaging of NK Cell Dynamics to Assess Heterogeneity in Motility and Cytotoxic Response.Single-cell profiling of dynamic cytokine secretion and the phenotype of immune cells.Magnetophoretic transistors in a tri-axial magnetic field.TriKEs and BiKEs join CARs on the cancer immunotherapy highway.A novel Fc-engineered human ICAM-1/CD54 antibody with potent anti-myeloma activity developed by cellular panning of phage display libraries.Natural killer cells and tumor metastasis.Regulatory Considerations for NK Cells Used in Human Immunotherapy Applications.

P2860

Q26774678-70A1698D-9CB9-450B-92D1-7D01664F6114 Q26775754-3894CD82-193D-4027-BAE5-B594E301E9DA Q27304436-AE3A6E13-1AC9-4788-A5A1-F564AF1D9C27 Q27329179-DE7FAC16-60C5-4569-90F0-C3834F918256 Q27345402-353F01FC-B95C-47A1-AA3A-044D955839F6 Q30276243-20672127-70AA-42E3-BBFC-D47F6C91D20E Q36067103-F9606248-724A-4970-9FFB-53A9FD0D3F93 Q36901142-27DAE362-79B3-4C7D-9FC2-1F716B89A64B Q36989586-2EB1E5FC-D337-4188-AF75-98207A61356E Q37072024-B7B26ABE-876E-4ED4-98C2-C29F264FA8EC Q37621530-F1BC0910-B3F1-441E-BBE7-FB2A2FA3E752 Q38654324-E31FA77C-1F23-4F7A-9755-F8D123BA8970 Q38700209-2711B417-47ED-4D57-8CFE-42DCD7B15CDA Q38730371-E4E2C5E6-2E36-4F9B-99B0-D498DBE6824D Q38731632-BB718B17-1809-4683-BBE9-B547D33CABEC Q38756767-F66230D3-B714-41D7-B84B-9E5DACD3EDCE Q38787705-8D6D8C69-5C18-4085-86D3-0A1E99A50881 Q39408704-C2E2EB72-ABA1-45A1-A056-71B0873A69EB Q39767913-01FABD99-1F18-4E21-A948-A8728C486333 Q40081116-E58075B5-7D38-4A2C-A5FA-33F936C32261 Q42381474-0BC844B8-0BF5-426E-A75B-C00249C3C488 Q42801713-F69BC159-6D8A-4644-9B5A-A57D807F8468 Q45761043-057D4236-C3AC-4756-B28B-918741F9069B Q48130583-61D81B8F-7928-4B4A-9020-FA6F78006C3E Q53099879-619DAA1C-9ECB-4B4E-8C07-96197884FA17

P2860

Antibody Fc engineering improves frequency and promotes kinetic boosting of serial killing mediated by NK cells.

http://www.wikidata.org/entity/Q34551199

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Antibody Fc engineering improv ...... killing mediated by NK cells.

@ast

Antibody Fc engineering improv ...... killing mediated by NK cells.

@en

Antibody Fc engineering improv ...... killing mediated by NK cells.

@nl

type

label

Antibody Fc engineering improv ...... killing mediated by NK cells.

@ast

Antibody Fc engineering improv ...... killing mediated by NK cells.

@en

Antibody Fc engineering improv ...... killing mediated by NK cells.

@nl

prefLabel

Antibody Fc engineering improv ...... killing mediated by NK cells.

@ast

Antibody Fc engineering improv ...... killing mediated by NK cells.

@en

Antibody Fc engineering improv ...... killing mediated by NK cells.

@nl

P1433

Q34551199-A7961749-E327-4068-9899-C6ADEA0E9BB2

P1476

Q34551199-16B191BF-F788-46BD-B440-08A6D709167F

P2093

Q34551199-0453C08C-AC07-44EB-9B5F-EF4C6F49AB69

Q34551199-295F8804-86C3-4E33-93D9-186AF3CCA3E6

Q34551199-2FFA90CF-2EAF-4173-9A64-6C0CDC3F0FD4

Q34551199-36D155BE-C9D8-472F-9D56-774A1C885CED

Q34551199-85BD92BB-E7C8-427B-8F41-475103D52D5C

Q34551199-B1D9F015-A8FF-42F7-827B-FF3EA00E639C

Q34551199-C52FE274-B254-4AC8-AE16-7D397F8A5A81

Q34551199-D3E099E0-5C84-4376-B9FA-005E63B14A0D

Q34551199-DD38F1BB-9262-4CC0-A06A-CB00CAB13E2A

Q34551199-F03177D2-476F-4C05-8F3E-B532BC5ACD45

P2860

Q34551199-15E4250B-4338-4955-8DFE-801F9CCD28C1

Q34551199-18371FAB-DE6C-4E1A-9695-269CA8D0410B

Q34551199-1AFC3B94-5029-47AB-A8EC-3474306F99AA

Q34551199-1B23D1C0-8A93-4905-9425-6835A1BF678C

Q34551199-1B4D6CC3-8EF1-4653-BE34-2DD08B00F60C

Q34551199-1EE0E444-2CC6-4846-93E2-E7CC0CF96687

Q34551199-2194DDB2-0C5D-4465-A805-E3DAAE1BF19D

Q34551199-2623C9AB-52BE-4244-BEB9-858644BD1EFD

Q34551199-336035BB-9A77-44AD-B619-D13530B7DE14

Q34551199-3BA30FFA-A980-497A-A534-F8B197295343

P304

Q34551199-35AE5244-7F31-4F55-AB52-B208AE4FF672

P31

Q34551199-B55C45C1-4224-4E70-8249-CF34E93C5379

P356

Q34551199-6FACB589-98B4-411D-AE1E-E01CC119DEF3

P407

Q34551199-FD3CB361-47A6-4746-B323-51612B2E6C55

P433

Q34551199-8A89318D-3F4A-4F75-811B-76D13E1A1071

P478

Q34551199-9FAA9D0D-6BF6-4D33-A621-929E48F8376E

P50

Q34551199-7FC7E2D4-53BF-48E4-BA2B-18733197FA8B

Q34551199-CB1281E8-329A-4B2B-8605-F6F50E9772FE

P577

Q34551199-C458C28C-1511-42BA-82DC-E7B8F8032117

P5875

Q34551199-282BD64A-06C1-4BC2-8066-BE50194F301C

P698

Q34551199-2F30D6E5-F3A5-4951-B023-69761D547B1A

P921

Q34551199-D4805AF0-FC8D-4C17-A179-05CEA1C7F911

P932

Q34551199-0F5767EF-993C-4B2D-928F-B8FDA811C6FC

P356

BLOOD-2014-04-569061

P1433

P1476

Antibody Fc engineering improv ...... l killing mediated by NK cells

@en

P2093

Amine Merouane

http://www.w3.org/2001/XMLSchema#string

Ankit Mahendra

http://www.w3.org/2001/XMLSchema#string

Badrinath Roysam

http://www.w3.org/2001/XMLSchema#string

Gabrielle Romain

http://www.w3.org/2001/XMLSchema#string

George Georgiou

http://www.w3.org/2001/XMLSchema#string

Ivan Liadi

http://www.w3.org/2001/XMLSchema#string

Navin Varadarajan

http://www.w3.org/2001/XMLSchema#string

Nicolas Rey-Villamizar

http://www.w3.org/2001/XMLSchema#string

Vladimir Senyukov

http://www.w3.org/2001/XMLSchema#string

Wissam Charab

http://www.w3.org/2001/XMLSchema#string

P2860

Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity

Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

Glycoengineering of therapeutic antibodies enhances monocyte/macrophage-mediated phagocytosis and cytotoxicity

Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized Daudi cells is promoted by NK cells and inhibited by monocytes due to shaving.

Imaging burst kinetics and spatial coordination during serial killing by single natural killer cells.

Aglycosylated IgG variants expressed in bacteria that selectively bind FcgammaRI potentiate tumor cell killing by monocyte-dendritic cells.

NK cell-based immunotherapy for malignant diseases.

Monoclonal antibodies: versatile platforms for cancer immunotherapy.

Engineered antibody Fc variants with enhanced effector function.

P304

3241-3249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2014-04-569061

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265791199

http://www.w3.org/2001/XMLSchema#string

P698

25232058

http://www.w3.org/2001/XMLSchema#string

P921

P932

4239333

http://www.w3.org/2001/XMLSchema#string